BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
VanEck Gold Miners ETF
GDX
|
+$135M |
| 2 |
CELG
Celgene Corp
CELG
|
+$131M |
| 3 |
Alibaba
BABA
|
+$85.8M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$76.3M |
| 5 |
Lam Research
LRCX
|
+$52.1M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.12B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$968M |
| 3 |
Apple
AAPL
|
+$681M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$649M |
| 5 |
Microsoft
MSFT
|
+$571M |
Sector Composition
| 1 | Technology | 15.07% |
| 2 | Financials | 12.59% |
| 3 | Healthcare | 10.85% |
| 4 | Consumer Discretionary | 10.71% |
| 5 | Industrials | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Potbelly
PBPB
$514M
| $185 | ﹤0.01% |
23
-764
| -97% | -$6.15K |
|
|
NVEE
3327
DELISTED
NV5 Global
NVEE
| $182 | ﹤0.01% |
12
-1,064
| -99% | -$16.1K |
|
|
CAMP
3328
DELISTED
CalAmp Corp.
CAMP
| $182 | ﹤0.01% |
1
-51
| -98% | -$9.28K |
|
|
IMGN
3329
DELISTED
Immunogen Inc
IMGN
| $182 | ﹤0.01% |
38
-4,185
| -99% | -$20K |
|
3330
QuinStreet
QNST
$912M
| $179 | ﹤0.01% |
11
-1,219
| -99% | -$19.8K |
|
3331
Triumph Financial, Inc.
TFIN
$1.42B
| $178 | ﹤0.01% |
6
-835
| -99% | -$24.8K |
|
3332
FB Financial Corp
FBK
$2.86B
| $175 | ﹤0.01% |
5
-428
| -99% | -$15K |
|
3333
NVE Corp
NVEC
$317M
| $175 | ﹤0.01% |
2
-163
| -99% | -$14.3K |
|
|
TSC
3334
DELISTED
TriState Capital Holdings, Inc.
TSC
| $175 | ﹤0.01% |
9
-757
| -99% | -$14.7K |
|
3335
Liquidia Corp
LQDA
$2.35B
| $173 | ﹤0.01% |
+8
| New | +$173 |
|
3336
Preferred Bank
PFBC
$1.17B
| $173 | ﹤0.01% |
4
-837
| -100% | -$36.2K |
|
3337
Barrett Business Services
BBSI
$1.18B
| $172 | ﹤0.01% |
12
-988
| -99% | -$14.2K |
|
3338
Par Pacific Holdings
PARR
$1.69B
| $170 | ﹤0.01% |
12
-1,042
| -99% | -$14.8K |
|
3339
Independent Bank Corp
IBCP
$661M
| $168 | ﹤0.01% |
8
-759
| -99% | -$15.9K |
|
3340
Wave Life Sciences
WVE
$1.18B
| $168 | ﹤0.01% |
4
-547
| -99% | -$23K |
|
3341
CytomX Therapeutics
CTMX
$341M
| $166 | ﹤0.01% |
11
-1,211
| -99% | -$18.3K |
|
3342
Cibus
CBUS
$73M
| – | – |
-6
| Closed | -$4.7K |
|
3343
Civitas Resources
CIVI
$3.13B
| $165 | ﹤0.01% |
8
-1,723
| -100% | -$35.5K |
|
3344
MacroGenics
MGNX
$109M
| $165 | ﹤0.01% |
13
-1,320
| -99% | -$16.8K |
|
|
NVLN
3345
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $165 | ﹤0.01% |
196
| – | – |
|
3346
Ingles Markets
IMKTA
$1.29B
| $163 | ﹤0.01% |
6
-477
| -99% | -$13K |
|
3347
Winmark
WINA
$1.76B
| $159 | ﹤0.01% |
1
-94
| -99% | -$14.9K |
|
3348
X4 Pharmaceuticals
XFOR
$76.1M
| – | – |
-1
| Closed | -$237 |
|
3349
Collegium Pharmaceutical
COLL
$1.19B
| $155 | ﹤0.01% |
9
-957
| -99% | -$16.5K |
|
3350
Farmers & Merchants Bancorp
FMAO
$353M
| $154 | ﹤0.01% |
4
-301
| -99% | -$11.6K |
|